- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
823
Companies which are more than 50% undervalued based on analyst price target.
823 companies
iTeos Therapeutics
Market Cap: US$255.1m
A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.
ITOS
US$6.92
7D
-3.7%
1Y
-59.3%
Atea Pharmaceuticals
Market Cap: US$253.3m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.
AVIR
US$2.63
7D
-6.1%
1Y
-33.6%
AprilBioLtd
Market Cap: ₩359.8b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩16,000.00
7D
3.0%
1Y
8.4%
BioStem Technologies
Market Cap: US$252.4m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$15.20
7D
9.4%
1Y
72.7%
Gossamer Bio
Market Cap: US$252.2m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$1.10
7D
-12.0%
1Y
52.8%
Compass Therapeutics
Market Cap: US$251.7m
A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.
CMPX
US$2.01
7D
8.1%
1Y
28.8%
Palvella Therapeutics
Market Cap: US$250.9m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.
PVLA
US$20.75
7D
-13.0%
1Y
n/a
Cutia Therapeutics
Market Cap: HK$2.0b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$6.13
7D
-1.3%
1Y
-13.3%
Verano Holdings
Market Cap: CA$348.9m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.01
7D
-9.8%
1Y
-86.7%
MaxCyte
Market Cap: UK£188.2m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
UK£1.72
7D
-15.3%
1Y
-54.5%
BioVersys
Market Cap: CHF 206.8m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 34.70
7D
-2.0%
1Y
n/a
Tarsons Products
Market Cap: ₹20.8b
Manufactures and trades in scientific plastic labware products in India and internationally.
TARSONS
₹391.65
7D
8.2%
1Y
-9.0%
Tvardi Therapeutics
Market Cap: US$243.2m
Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.
TVRD
US$26.54
7D
1.1%
1Y
n/a
Lexicon Pharmaceuticals
Market Cap: US$243.1m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
LXRX
US$0.63
7D
-3.9%
1Y
-67.2%
Astria Therapeutics
Market Cap: US$238.7m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$4.37
7D
-14.5%
1Y
-55.0%
Zhejiang Taimei Medical Technology
Market Cap: HK$1.9b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$3.30
7D
-5.2%
1Y
n/a
Acelyrin
Market Cap: US$237.7m
A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
SLRN
US$2.48
7D
-2.4%
1Y
-47.1%
Candel Therapeutics
Market Cap: US$237.0m
A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.
CADL
US$5.01
7D
0.6%
1Y
-50.9%
Bright Minds Biosciences
Market Cap: CA$327.4m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$45.71
7D
11.5%
1Y
2,811.5%
Foghorn Therapeutics
Market Cap: US$233.6m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$4.43
7D
14.2%
1Y
-21.9%
Vanda Pharmaceuticals
Market Cap: US$232.8m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.03
7D
-12.2%
1Y
-20.2%
Creative Medical Technology Holdings
Market Cap: US$232.3m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.00
7D
1.0%
1Y
-55.0%
Canopy Growth
Market Cap: CA$324.3m
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
WEED
CA$2.01
7D
13.6%
1Y
-84.9%
Oryzon Genomics
Market Cap: €208.5m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.63
7D
0.8%
1Y
29.6%
Quantum-Si
Market Cap: US$230.8m
A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
QSI
US$1.51
7D
25.8%
1Y
-12.2%
Aardvark Therapeutics
Market Cap: US$226.1m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$10.97
7D
4.1%
1Y
n/a
Rezolute
Market Cap: US$225.8m
A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
RZLT
US$3.67
7D
-2.4%
1Y
36.9%
Solid Biosciences
Market Cap: US$224.8m
Develops therapies for neuromuscular and cardiac diseases in the United States.
SLDB
US$2.79
7D
-17.2%
1Y
-72.0%
BioInvent International
Market Cap: SEK 2.2b
A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 32.95
7D
2.2%
1Y
20.5%
Phathom Pharmaceuticals
Market Cap: US$219.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.
PHAT
US$3.31
7D
37.9%
1Y
-68.1%
Codexis
Market Cap: US$218.7m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.56
7D
13.5%
1Y
-29.9%
Genfit
Market Cap: €194.0m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.84
7D
-6.7%
1Y
12.3%
Monopar Therapeutics
Market Cap: US$214.6m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$33.82
7D
-12.8%
1Y
939.0%
ProKidney
Market Cap: US$211.2m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$0.75
7D
-0.4%
1Y
-75.6%
Neurogene
Market Cap: US$210.1m
A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.
NGNE
US$17.70
7D
17.1%
1Y
-42.2%
Fuji Pharma
Market Cap: JP¥31.1b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,273.00
7D
-6.5%
1Y
-16.1%